D.L. Carlson Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-41,245
| Closed | -$1.86M | – | 136 |
|
|
2025
Q3 | $1.86M | Sell |
41,245
-2,881
| -7% | -$135K | 0.31% | 77 |
|
|
2025
Q2 | $2.04M | Buy |
44,126
+19,363
| +78% | +$950K | 0.37% | 70 |
|
|
2025
Q1 | $1.51M | Buy |
+24,763
| New | +$1.44M | 0.29% | 84 |
|
|
2024
Q2 | – | Sell |
-33,174
| Closed | -$1.8M | – | 138 |
|
|
2024
Q1 | $1.8M | Sell |
33,174
-1,612
| -5% | -$82.1K | 0.35% | 75 |
|
|
2023
Q4 | $1.72M | Sell |
34,786
-32,773
| -49% | -$1.72M | 0.35% | 72 |
|
|
2023
Q3 | $3.92M | Sell |
67,559
-2,345
| -3% | -$144K | 0.79% | 45 |
|
|
2023
Q2 | $4.47M | Sell |
69,904
-462
| -0.7% | -$31K | 0.85% | 42 |
|
|
2023
Q1 | $4.88M | Sell |
70,366
-6,146
| -8% | -$433K | 1.11% | 34 |
|
|
2022
Q4 | $5.5M | Sell |
76,512
-5,822
| -7% | -$439K | 1.18% | 30 |
|
|
2022
Q3 | $5.85M | Sell |
82,334
-14,315
| -15% | -$1.04M | 1.27% | 22 |
|
|
2022
Q2 | $7.44M | Buy |
96,649
+270
| +0.3% | +$20.6K | 1.57% | 17 |
|
|
2022
Q1 | $7.04M | Sell |
96,379
-528
| -0.5% | -$35.5K | 1.17% | 24 |
|
|
2021
Q4 | $6.04M | Sell |
96,907
-14,464
| -13% | -$848K | 0.96% | 39 |
|
|
2021
Q3 | $6.59M | Buy |
111,371
+3,167
| +3% | +$209K | 1.15% | 31 |
|
|
2021
Q2 | $7.23M | Buy |
108,204
+25,801
| +31% | +$1.68M | 1.25% | 30 |
|
|
2021
Q1 | $5.2M | Buy |
82,403
+9,360
| +13% | +$582K | 0.95% | 46 |
|
|
2020
Q4 | $4.53M | Sell |
73,043
-2,587
| -3% | -$159K | 0.82% | 50 |
|
|
2020
Q3 | $4.56M | Buy |
75,630
+30,746
| +69% | +$1.85M | 0.97% | 39 |
|
|
2020
Q2 | $2.64M | Buy |
44,884
+7,644
| +21% | +$457K | 0.79% | 47 |
|
|
2020
Q1 | $2.08M | Sell |
37,240
-17,474
| -32% | -$1.07M | 0.78% | 48 |
|
|
2019
Q4 | $3.51M | Sell |
54,714
-24
| -0% | -$1.37K | 1.02% | 37 |
|
|
2019
Q3 | $2.78M | Buy |
54,738
+11,012
| +25% | +$518K | 0.87% | 40 |
|
|
2019
Q2 | $1.98M | Sell |
43,726
-4,199
| -9% | -$196K | 0.61% | 61 |
|
|
2019
Q1 | $2.29M | Buy |
47,925
+3,637
| +8% | +$181K | 0.67% | 60 |
|
|
2018
Q4 | $2.3M | Sell |
44,288
-28,664
| -39% | -$1.54M | 0.76% | 50 |
|
|
2018
Q3 | $4.53M | Buy |
72,952
+15,612
| +27% | +$926K | 1.28% | 27 |
|
|
2018
Q2 | $3.17M | Sell |
57,340
-29,892
| -34% | -$1.61M | 0.97% | 44 |
|
|
2018
Q1 | $5.52M | Buy |
87,232
+28,193
| +48% | +$1.81M | 1.74% | 14 |
|
|
2017
Q4 | $3.62M | Buy |
59,039
+5,087
| +9% | +$318K | 1.07% | 36 |
|
|
2017
Q3 | $3.44M | Buy |
53,952
+46,852
| +660% | +$2.74M | 1.07% | 38 |
|
|
2017
Q2 | $396K | Hold |
7,100
| – | – | 0.12% | 114 |
|
|
2017
Q1 | $386K | Sell |
7,100
-36,670
| -84% | -$2.01M | 0.13% | 107 |
|
|
2016
Q4 | $2.56M | Sell |
43,770
-4,470
| -9% | -$244K | 0.87% | 53 |
|
|
2016
Q3 | $2.6M | Sell |
48,240
-1,280
| -3% | -$82.2K | 0.9% | 54 |
|
|
2016
Q2 | $3.64M | Sell |
49,520
-26,965
| -35% | -$1.91M | 1.3% | 28 |
|
|
2016
Q1 | $4.89M | Buy |
76,485
+5,855
| +8% | +$369K | 1.82% | 10 |
|
|
2015
Q4 | $4.86M | Sell |
70,630
-232
| -0.3% | -$15.3K | 1.81% | 9 |
|
|
2015
Q3 | $4.2M | Sell |
70,862
-553
| -0.8% | -$35.1K | 1.69% | 16 |
|
|
2015
Q2 | $4.75M | Buy |
71,415
+5,012
| +8% | +$330K | 1.72% | 10 |
|
|
2015
Q1 | $4.28M | Buy |
66,403
+445
| +0.7% | +$27.9K | 1.52% | 14 |
|
|
2014
Q4 | $3.89M | Buy |
65,958
+5,593
| +9% | +$315K | 1.41% | 16 |
|
|
2014
Q3 | $3.09M | Sell |
60,365
-775
| -1% | -$38.7K | 1.16% | 32 |
|
|
2014
Q2 | $2.97M | Sell |
61,140
-15,925
| -21% | -$785K | 1.08% | 39 |
|
|
2014
Q1 | $4M | Buy |
77,065
+62,700
| +436% | +$3.34M | 1.5% | 16 |
|
|
2013
Q4 | $763K | Sell |
14,365
-876
| -6% | -$44.6K | 0.28% | 91 |
|
|
2013
Q3 | $705K | Sell |
15,241
-455
| -3% | -$20K | 0.27% | 88 |
|
|
2013
Q2 | $701K | Buy |
+15,696
| New | +$681K | 0.28% | 86 |
|
Other funds holding BMY
D.L. Carlson Investment Group's BMY Position: Q4 2025 in Review
D.L. Carlson Investment Group sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 41,245 shares — an estimated $1.86M sold.
D.L. Carlson Investment Group first reported a position in BMY in Q2 2013 and held it in 47 quarters. The position peaked at $7.44M in Q2 2022. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- D.L. Carlson Investment Group reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- D.L. Carlson Investment Group sold 41,245 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.86M.
- D.L. Carlson Investment Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 47 quarters.
- D.L. Carlson Investment Group's Bristol-Myers Squibb position peaked at $7.44M in Q2 2022.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on D.L. Carlson Investment Group's 13F filing for Q4 2025, filed 17 Feb 2026.